Clinical Trial Update: A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating belumosudil for moderate-to-severe chronic plaque psoriasis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Kadmon Corporation, LLC | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-09-13